New Therapeutic Aspects of Inflammatory Cardiomyopathy

Title:New Therapeutic Aspects of Inflammatory Cardiomyopathy

Volume: 21 Issue: 4

Author(s): Petr Kuchynka, Tomas Palecek, Eduard Nemecek, Michal Fikrle and Ales Linhart

Affiliation:

Keywords: Myocarditis, inflammatory cardiomyopathy, endomyocardial biopsy, immunosuppression, antimicrobial treatment.

Abstract: Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.

Cite this article as:

Kuchynka Petr, Palecek Tomas, Nemecek Eduard, Fikrle Michal and Linhart Ales, New Therapeutic Aspects of Inflammatory Cardiomyopathy, Current Pharmaceutical Design 2015; 21 (4) . https://dx.doi.org/10.2174/138161282104141204142244